{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:06:44Z","timestamp":1778548004528,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.biopha.2017.05.113","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T01:46:59Z","timestamp":1496540819000},"page":"726-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats"],"prefix":"10.1016","volume":"92","author":[{"given":"Bibi Marjan","family":"Razavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fariba","family":"Lookian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Hosseinzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.05.113_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.med.58.060904.084114","article-title":"Schizophrenia: new pathological insights and therapies","volume":"58","author":"Jarskog","year":"2007","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.biopha.2017.05.113_bib0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2002-36391","article-title":"Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives","volume":"35","author":"Baptista","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.biopha.2017.05.113_bib0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MED.0b013e32833de61c","article-title":"Metabolic syndrome with the atypical antipsychotics","volume":"17","author":"Pramyothin","year":"2010","journal-title":"Curr. Opin. Endocrinol. Diab. Obes."},{"key":"10.1016\/j.biopha.2017.05.113_bib0020","first-page":"292","article-title":"Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications","author":"Riordan","year":"2011","journal-title":"Am. Health Drug Benefits"},{"key":"10.1016\/j.biopha.2017.05.113_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1639-8","article-title":"Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors","volume":"207","author":"Kirk","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2017.05.113_bib0030","first-page":"36","article-title":"Psychotropic-induced weight gain and potential pharmacologic treatment strategies","volume":"2","author":"Gracious","year":"2005","journal-title":"Psychiatry"},{"key":"10.1016\/j.biopha.2017.05.113_bib0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/JCP.0b013e31819302c3","article-title":"Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine","volume":"29","author":"Gunes","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2017.05.113_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pbb.2010.05.029","article-title":"Olanzapine causes hypothermia inactivity, a deranged feeding pattern and weight gain in female Wistar rats","volume":"97","author":"Evers","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2017.05.113_bib0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","article-title":"Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats","volume":"217","author":"Weston-Greena","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2017.05.113_bib0050","series-title":"Green Tea: Health Benefits and Applications","author":"Hara","year":"2001"},{"key":"10.1016\/j.biopha.2017.05.113_bib0055","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1021\/jf980223x","article-title":"Survey of catechins gallic acid, and methylxanthines in green, oolong, pu-erh, and black teas","volume":"46","author":"Lin","year":"1998","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2017.05.113_bib0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.17795\/jjnpp-18406","article-title":"Protective effect of green tea aqueous extract on acrylamide induced neurotoxicity","volume":"10","author":"Esmaeelpanah","year":"2015","journal-title":"Jundishapur J. Nat. Pharm. Prod."},{"key":"10.1016\/j.biopha.2017.05.113_bib0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mnfr.200500102","article-title":"Anti-obesity effects of green tea: from bedside to bench","volume":"50","author":"Wolfram","year":"2006","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2017.05.113_bib0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.fct.2016.11.035","article-title":"Protective effects of green tea and its main constituents against natural and chemical toxins: a comprehensive review","volume":"100","author":"Rameshrad","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2017.05.113_bib0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2010.12.013","article-title":"Weight control and prevention of metabolic syndrome by green tea","volume":"64","author":"Sae-tan","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2017.05.113_bib0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004850-200207000-00001","article-title":"Options for pharmacological management of obesity in patients treated with atypical antipsychotics","volume":"17","author":"Werneke","year":"2002","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"30","key":"10.1016\/j.biopha.2017.05.113_bib0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ptr.5570","article-title":"Grapes (Vitis vinifera) as a potential candidate for the therapy of the metabolic syndrome","volume":"30","author":"Akaberi","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2017.05.113_bib0090","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40618-014-0150-1","article-title":"A review of the effects of Nigella sativa L. and its constituent thymoquinone, in metabolic syndrome","volume":"37","author":"Razavi","year":"2014","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.biopha.2017.05.113_bib0095","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s40618-015-0313-8","article-title":"A review on the effects of Allium sativum (Garlic) in metabolic syndrome","volume":"38","author":"Hosseini","year":"2015","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.biopha.2017.05.113_bib0100","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00210-016-1256-0","article-title":"Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review, Naunyn Schmiedebergs","volume":"389","author":"Hassani","year":"2016","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.113_bib0105","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jsfa.8134","article-title":"Saffron: a promising natural medicine in the treatment of metabolic syndrome","volume":"97","author":"Razavi","year":"2017","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.biopha.2017.05.113_bib0110","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.5805","article-title":"Effects of avocado (Persea americana) on metabolic syndrome: a comprehensive systematic review","author":"Tabeshpour","year":"2017","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2017.05.113_bib0115","first-page":"1258","article-title":"Cinnamon effects on metabolic syndrome: a review based on its mechanisms","volume":"19","author":"Mollazadeh","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.biopha.2017.05.113_bib0120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40618-014-0096-3","article-title":"Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid","volume":"37","author":"Hosseinzadeh","year":"2014","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.biopha.2017.05.113_bib0125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nutres.2011.01.005","article-title":"Green tea aqueous extract reduces visceral fat and decreases protein availability in rats fed with a high-fat diet","volume":"31","author":"Bajerska","year":"2011","journal-title":"Nutr. Res."},{"key":"10.1016\/j.biopha.2017.05.113_bib0130","first-page":"811","article-title":"The analysis of quality and antioxidant activity of green tea extracts","volume":"5","author":"Armoskaite","year":"2011","journal-title":"J. Med. Plants Res."},{"key":"10.1016\/j.biopha.2017.05.113_bib0135","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.lfs.2007.08.009","article-title":"Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats","volume":"81","author":"Choi","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2017.05.113_bib0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2006.09.009","article-title":"Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain","volume":"551","author":"Patil","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.113_bib0145","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1007\/s00213-014-3540-3","article-title":"Phosphorylation of hypothalamic AMPK on serine485\/491 related to sustained weight loss by alpha-lipoic acid in mice treated with olanzapine","volume":"231","author":"Kim","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.biopha.2017.05.113_bib0150","first-page":"121","article-title":"An animal model of antipsychotic-induced weight gain","volume":"152","author":"Arjona","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2017.05.113_bib0155","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004583-200203000-00014","article-title":"Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study","volume":"41","author":"Ratzoni","year":"2002","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.biopha.2017.05.113_bib0160","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments. Meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2017.05.113_bib0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.biopha.2017.05.113_bib0170","first-page":"S26","article-title":"Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis","volume":"60","author":"Potvin","year":"2015","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.biopha.2017.05.113_bib0175","doi-asserted-by":"crossref","first-page":"T47","DOI":"10.1530\/JOE-13-0339","article-title":"Adipocytokines in obesity and metabolic disease","volume":"220","author":"Cao","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2017.05.113_bib0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.jcp.0000085403.08426.f4","article-title":"Antipsychotic-induced weight gain: bipolar disorder and leptin","volume":"23","author":"McIntyre","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.biopha.2017.05.113_bib0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/10401230490453293","article-title":"Atypical antipsychotic induced weight gain: pathophysiology and management","volume":"16","author":"Ananth","year":"2004","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2017.05.113_bib0190","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s10571-011-9663-8","article-title":"A role for hypothalamic AMP-activated protein kinase in the mediation of hyperphagia and weight gain induced by chronic treatment with olanzapine in female rats","volume":"31","author":"Sejima","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.05.113_bib0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3945\/ajcn.2009.28157","article-title":"Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis","volume":"91","author":"Phung","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2017.05.113_bib0200","first-page":"1677","article-title":"The major green tea polyphenol (\u2212)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice","volume":"138","author":"Bose","year":"2008","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2017.05.113_bib0205","first-page":"481","article-title":"Effects of green tea on growth, food utilization and lipid metabolism in mice","volume":"14","author":"Sayama","year":"2000","journal-title":"In Vivo"},{"key":"10.1016\/j.biopha.2017.05.113_bib0210","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0024-3205(03)00468-5","article-title":"Stimulatory effect of oral administration of green tea and caffeine on locomotor activity in SKH-1 mice","volume":"73","author":"Michna","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2017.05.113_bib0215","doi-asserted-by":"crossref","first-page":"103e7","DOI":"10.1016\/j.jecm.2012.01.007","article-title":"Metabolic and cardiovascular adverse effects associated with treatment with antipsychotic drugs","volume":"4","author":"Chang","year":"2012","journal-title":"J. Exp. Clin. Med."},{"key":"10.1016\/j.biopha.2017.05.113_bib0220","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.biopha.2017.05.113_bib0225","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1445-5994.2008.01712.x","article-title":"Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms","volume":"38","author":"Buchholz","year":"2008","journal-title":"Int. Med. J."},{"key":"10.1016\/j.biopha.2017.05.113_bib0230","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-144-8-200604180-00005","article-title":"The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults","volume":"144","author":"Iso","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2017.05.113_bib0235","first-page":"2512","article-title":"Epigallocatechin gallate supplementation alleviates diabetes in rodents","volume":"136","author":"Wolfram","year":"2006","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2017.05.113_bib0240","doi-asserted-by":"crossref","first-page":"34933","DOI":"10.1074\/jbc.M204672200","article-title":"Epigallocatechin gallate aconstituent of green tea, represses hepatic glucose production","volume":"277","author":"Waltner-Law","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2017.05.113_bib0245","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1021\/jf020514c","article-title":"Tea enhances insulin activity","volume":"50","author":"Anderson","year":"2002","journal-title":"Agric. Food Chem. J."},{"key":"10.1016\/j.biopha.2017.05.113_bib0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2210-4-18","article-title":"Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db\/db) mice and on glucose metabolism in healthy humans","volume":"4","author":"Tsuneki","year":"2004","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.biopha.2017.05.113_bib0255","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/emm.2003.19","article-title":"Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage","volume":"35","author":"Han","year":"2003","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2017.05.113_bib0260","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1021\/jf0006832","article-title":"Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism","volume":"48","author":"Kobayashi","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2017.05.113_bib0265","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nutres.2012.05.007","article-title":"Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients","volume":"32","author":"Bogdanskia","year":"2012","journal-title":"Nutr. Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217314269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217314269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:50:47Z","timestamp":1772265047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217314269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":53,"alternative-id":["S0753332217314269"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.113","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.05.113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}